Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

ClinicalTrials.gov ID: NCT00006412

Public ClinicalTrials.gov record NCT00006412. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Randomized Trial Comparing the Efficacy and Safety of Fenofibrate Versus Pravastatin in HIV-Infected Subjects With Lipid Abnormalities

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and effectiveness of fenofibrate and pravastatin in treating HIV-positive patients who have abnormal levels of fat (lipids) in the blood. Increased lipids in the blood associated with HIV infection and anti-HIV drugs is a growing problem. The drugs used in this study are known to reduce certain lipids, but little is known about their safety and effectiveness. This study will see if one of the drugs is safer and more effective than the other, or if combining the drugs is the safest and most effective way to lower lipids. This study has been changed. On June 26, 2001, this study was reviewed by the Data and Safety Monitoring Board (DSMB). The DSMB is an independent board monitoring the progress of the study. The review showed that neither pravastatin nor fenofibrate alone were effective in reaching all the cholesterol and triglyceride goals. There were no safety concerns. It is not known if the combination of fenofibrate and pravastatin is effective and safe. Therefore, it is important to continue this study.

Study identification

NCT ID
NCT00006412
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
630 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
May 2003 (Actual)
Last update posted
Nov 1, 2021

Ends 2003

United States locations

U.S. sites
57
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294 —
Univ of Southern California / LA County USC Med Ctr Los Angeles California 900331079 —
UCLA CARE Ctr Los Angeles California 90095 —
Willow Clinic Menlo Park California 94025 —
Univ of California, San Diego San Diego California 92103 —
University of California San Francisco San Francisco California 941104206 —
Univ of California San Francisco San Francisco California 94110 —
San Mateo AIDS Program / Stanford Univ Stanford California 943055107 —
Stanford Univ Med Ctr Stanford California 943055107 —
Harbor UCLA Med Ctr Torrance California 90502 —
Denver Dept of Health and Hosps Denver Colorado 80262 —
Univ of Colorado Health Sciences Ctr Denver Colorado 80262 —
Univ of Miami School of Medicine Miami Florida 331361013 —
Emory Univ Atlanta Georgia 30308 —
Univ of Hawaii Honolulu Hawaii 96816 —
Tripler Army Med Ctr Tripler AMC Hawaii 96859 —
Northwestern Univ Med School Chicago Illinois 60611 —
The CORE Ctr Chicago Illinois 60612 —
Indiana Univ Hosp Indianapolis Indiana 462025250 —
Methodist Hosp of Indiana / Life Care Clinic Indianapolis Indiana 46202 —
Wishard Hosp Indianapolis Indiana 46202 —
Johns Hopkins Hosp Baltimore Maryland 21287 —
Harvard (Massachusetts Gen Hosp) Boston Massachusetts 02114 —
Boston Med Ctr Boston Massachusetts 02118 —
Beth Israel Deaconess - West Campus Boston Massachusetts 02215 —
Brigham and Women's Hosp Boston Massachusetts 02215 —
Univ of Minnesota Minneapolis Minnesota 55455 —
Univ of Nebraska Med Ctr Omaha Nebraska 681985130 —
SUNY / Erie County Med Ctr at Buffalo Buffalo New York 14215 —
Beth Israel Med Ctr New York New York 10003 —
Cornell Clinical Trials Unit - Chelsea Clinic New York New York 10011 —
Bellevue Hosp / New York Univ Med Ctr New York New York 10016 —
Cornell Univ Med Ctr New York New York 10021 —
Mount Sinai Med Ctr New York New York 10029 —
Columbia Presbyterian Med Ctr New York New York 10032 —
Community Health Network Inc Rochester New York 14642 —
St Mary's Hosp (Univ of Rochester/Infectious Diseases) Rochester New York 14642 —
Univ of Rochester Medical Center Rochester New York 14642 —
Univ of North Carolina Chapel Hill North Carolina 275997215 —
Carolinas Med Ctr Charlotte North Carolina 28203 —
Duke Univ Med Ctr Durham North Carolina 27710 —
Moses H Cone Memorial Hosp Greensboro North Carolina 27401 —
Univ of Cincinnati Cincinnati Ohio 452670405 —
Case Western Reserve Univ Cleveland Ohio 44106 —
MetroHealth Med Ctr Cleveland Ohio 441091998 —
Ohio State Univ Hosp Clinic Columbus Ohio 432101228 —
Philadelphia Veterans Administration Med Ctr Philadelphia Pennsylvania 19104 —
Univ of Pennsylvania Philadelphia Pennsylvania 19104 —
Univ of Pittsburgh Pittsburgh Pennsylvania 15213 —
Rhode Island Hosp / Brown Univ Providence Rhode Island 02903 —
Brown Univ / Miriam Hosp Providence Rhode Island 02906 —
Miriam Hosp / Brown Univ Providence Rhode Island 02906 —
Julio Arroyo West Columbia South Carolina 29169 —
Vanderbilt Univ Med Ctr Nashville Tennessee 37203 —
Univ of Texas, Southwestern Med Ctr of Dallas Dallas Texas 75390 —
Univ of Texas Galveston Galveston Texas 775550435 —
Univ of Washington Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006412, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2021 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00006412 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →